. . . New Long-Term SAM For Our BioHeads . . .
DRMD . . .Makes Cenestin, an artificial estrogen at about 20% discount. About 20% of perscriptions being written for Cenestin over Premarin. . . which costs about $44 per 100 units. . . . Outstanding earnings report in July. biz.yahoo.com
HMO's, etc. and Insurance companies are slowly adopting this lower price alternative. Recent list of news: biz.yahoo.com
About Duramed Pharmaceuticals, Inc.
Duramed Pharmaceuticals develops, manufactures and markets prescription drug products. The company's
business strategy emphasizes products with attractive market opportunities and potentially limited competition
due to technological barriers to entry, focusing on women's health and the hormone replacement therapy market.
On March 24, 1999, the FDA approved the company's first branded product, Cenestin® (synthetic conjugated
estrogens, A) Tablets, for the treatment of moderate-to-severe vasomotor symptoms associated with
menopause.
Duramed's containment manufacturing facility for the production of hormones -- with enclosed product flow and
state-of-the-art environmental controls -- ensures purity, stability and tablet uniformity for Cenestin and other
hormone products. While Duramed's primary focus will be solid oral dose hormones, the company's other areas
of concentration -- controlled release technology and oncology -- continue to represent attractive market
opportunities that will be pursued, as appropriate.
The company's stock is traded on Nasdaq using the symbol DRMD. Additional information about the company
can be found on the World Wide Web at duramed.com and cenestin.com .
(1) Premarin is a trademark of Wyeth-Ayerst Laboratories.
This one goes in the drawer for several years.
Rande Is |
